Showing results (121-130 of 219) with videos related to
Sort By:
Pageof 22
Cancer Research|November 15, 1991
Action of 2',2'-difluorodeoxycytidine on DNA synthesisP Huang, S Chubb, L W Hertel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology studyR Grunewald, H Kantarjian, M Du, et al.Nature|October 3, 2000
Superoxide dismutase as a target for the selective killing of cancer cellsP Huang, L Feng, E A Oldham, et al.International Journal of Molecular Medicine|May 17, 2000
Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damageL Feng, G Achanta, H Pelicano, et al.The Journal of Biological Chemistry|February 5, 1992
Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphateS W Yang, P Huang, W Plunkett, et al.Seminars in Oncology|August 1, 1995
Gemcitabine: metabolism, mechanisms of action, and self-potentiationW Plunkett, P Huang, Y Z Xu, et al.Leukemia & Lymphoma|January 1, 1993
Chronic lymphocytic leukemia--correlation of response and survivalM J Keating, S O'Brien, L Robertson, et al.Cancer Research|February 28, 2001
S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporineZ Shi, A Azuma, D Sampath, et al.Leukemia|August 15, 2000
Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabineP Huang, A Sandoval, E Van Den Neste, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemiaV Gandhi, E Estey, M Du, et al.Pageof 22